In last trading session, Protagenic Therapeutics Inc (NASDAQ:PTIX) saw 13.44 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $0.23 trading at -$0.02 or -9.20% at ring of the bell on the day assigns it a market valuation of $1.71M. That closing price of PTIX’s stock is at a discount of -713.04% from its 52-week high price of $1.87 and is indicating a premium of 21.74% from its 52-week low price of $0.18. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.88 million shares which gives us an average trading volume of 2.08 million if we extend that period to 3-months.

Protagenic Therapeutics Inc (NASDAQ:PTIX) trade information

Upright in the red during last session for losing -9.20%, in the last five days PTIX remained trading in the red while hitting it’s week-highest on Tuesday, 04/01/25 when the stock touched $0.23 price level, adding 17.33% to its value on the day. Protagenic Therapeutics Inc’s shares saw a change of -53.67% in year-to-date performance and have moved -13.69% in past 5-day. Protagenic Therapeutics Inc (NASDAQ:PTIX) showed a performance of -38.33% in past 30-days. Number of shares sold short was 0.19 million shares which calculate 0.03 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -10.56% during past 5 years.

Protagenic Therapeutics Inc (NASDAQ:PTIX)’s Major holders

Insiders are in possession of 13.43% of company’s total shares while institution are holding 5.38 percent of that, with stock having share float percentage of 6.22%. Investors also watch the number of corporate investors in a company very closely, which is 5.38% institutions for Protagenic Therapeutics Inc that are currently holding shares of the company.